Not Yet Recruiting OBSERVATIONAL NCT05017402

Higher Dose of Alglucosidase Alpha for Pompe Disease

Higher Dose of Alglucosidase Alpha for Pompe Disease: Long-term Follow-up Study

Sponsor: Taipei Veterans General Hospital, Taiwan

Conditions Glycogen Storage Disease Type II

Updated 3 times since 2021 Last updated: Aug 17, 2021 Started: Sep 1, 2021 Primary completion: Dec 31, 2023 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Glycogen Storage Disease Type II, this trial is actively recruiting participants. The trial is conducted by Taipei Veterans General Hospital, Taiwan and has accumulated 3 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Sep 2021 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Taipei Veterans General Hospital, Taiwan

Data source: Taipei Veterans General Hospital, Taiwan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.